• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我是否应该接受昏睡病筛查?刚果民主共和国开赛省的定性研究。

Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.

机构信息

Programme National de Lutte contre la Trypanosomiase Humaine Africain, Kinshasa, Democratic Republic of Congo.

出版信息

PLoS Negl Trop Dis. 2012 Jan;6(1):e1467. doi: 10.1371/journal.pntd.0001467. Epub 2012 Jan 17.

DOI:10.1371/journal.pntd.0001467
PMID:22272367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260312/
Abstract

BACKGROUND

Control of human African trypanosomiasis (sleeping sickness) in the Democratic Republic of Congo is based on mass population active screening by mobile teams. Although generally considered a successful strategy, the community participation rates in these screening activities and ensuing treatment remain low in the Kasai-Oriental province. A better understanding of the reasons behind this observation is necessary to improve regional control activities.

METHODS

Thirteen focus group discussions were held in five health zones of the Kasai-Oriental province to gain insights in the regional perceptions regarding sleeping sickness and the national control programme's activities.

PRINCIPAL FINDINGS

Sleeping sickness is well known among the population and is considered a serious and life-threatening disease. The disease is acknowledged to have severe implications for the individual (e.g., persistence of manic periods and trembling hands, even after treatment), at the family level (e.g., income loss, conflicts, separations) and for communities (e.g., disruption of community life and activities). Several important barriers to screening and treatment were identified. Fear of drug toxicity, lack of confidentiality during screening procedures, financial barriers and a lack of communication between the mobile teams and local communities were described. Additionally, a number of regionally accepted prohibitions related to sleeping sickness treatment were described that were found to be a strong impediment to disease screening and treatment. These prohibitions, which do not seem to have a rational basis, have far-reaching socio-economic repercussions and severely restrict the participation in day-to-day life.

CONCLUSIONS/SIGNIFICANCE: A mobile screening calendar more adapted to the local conditions with more respect for privacy, the use of less toxic drugs, and a better understanding of the origin as well as better communication about the prohibitions related to treatment would facilitate higher participation rates among the Kasai-Oriental population in sleeping sickness screening and treatment activities organized by the national HAT control programme.

摘要

背景

在刚果民主共和国,控制人类非洲锥虫病(昏睡病)的方法是通过移动小组对人群进行大规模主动筛查。尽管这种方法通常被认为是成功的策略,但在东方省的卡赛地区,社区参与这些筛查活动和随后治疗的比例仍然很低。为了改善区域控制活动,有必要更好地了解这一观察结果背后的原因。

方法

在东方省的五个卫生区进行了 13 次焦点小组讨论,以了解该地区对昏睡病和国家控制规划活动的看法。

主要发现

昏睡病在人群中广为人知,被认为是一种严重且危及生命的疾病。这种疾病被认为对个人有严重影响(例如,即使在治疗后,躁狂期和颤抖的手仍会持续存在),对家庭有严重影响(例如,收入损失、冲突、分离),对社区也有严重影响(例如,社区生活和活动的中断)。确定了筛查和治疗的几个重要障碍。描述了对药物毒性的恐惧、筛查过程中缺乏保密性、经济障碍以及移动小组与当地社区之间缺乏沟通等问题。此外,还描述了一些与昏睡病治疗相关的被该地区接受的禁令,这些禁令被发现是疾病筛查和治疗的严重障碍。这些禁令似乎没有合理的依据,对社会经济产生了深远的影响,严重限制了人们参与日常生活。

结论/意义:更适应当地条件的移动筛查日历,对隐私有更多尊重,使用毒性更小的药物,更好地了解禁忌的起源,并更好地传达与治疗相关的禁忌,将有助于提高卡赛地区人民对国家 HAT 控制规划组织的昏睡病筛查和治疗活动的参与率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/3260312/517bef641fe8/pntd.0001467.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/3260312/517bef641fe8/pntd.0001467.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b5/3260312/517bef641fe8/pntd.0001467.g001.jpg

相似文献

1
Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.我是否应该接受昏睡病筛查?刚果民主共和国开赛省的定性研究。
PLoS Negl Trop Dis. 2012 Jan;6(1):e1467. doi: 10.1371/journal.pntd.0001467. Epub 2012 Jan 17.
2
From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.从健康建议到禁忌:刚果民主共和国关于昏睡病治疗的社区观点,一项定性研究
PLoS Negl Trop Dis. 2015 Apr 9;9(4):e0003686. doi: 10.1371/journal.pntd.0003686. eCollection 2015 Apr.
3
Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.药物毒性和成本成为刚果民主共和国社区参与昏睡病控制的障碍。
Trop Med Int Health. 2007 Feb;12(2):290-8. doi: 10.1111/j.1365-3156.2006.01768.x.
4
Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.刚果民主共和国的人类非洲锥虫病:疾病分布与风险
Int J Health Geogr. 2015 Jun 6;14:20. doi: 10.1186/s12942-015-0013-9.
5
Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program.刚果民主共和国人体非洲锥虫病的治疗结果:来自世界上最大的昏睡病控制规划的常规规划数据分析。
Trop Med Int Health. 2012 Sep;17(9):1127-32. doi: 10.1111/j.1365-3156.2012.03042.x. Epub 2012 Jul 19.
6
Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions.将人体非洲锥虫病控制活动融入刚果民主共和国初级卫生服务中:利益攸关方认知的定性研究。
Am J Trop Med Hyg. 2019 Apr;100(4):899-906. doi: 10.4269/ajtmh.18-0382.
7
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.在刚果民主共和国,美拉胂醇治疗昏睡病的失败率很高。
Emerg Infect Dis. 2008 Jun;14(6):966-7. doi: 10.3201/eid1406.071266.
8
In the heart of darkness: sleeping sickness in Zaire.在黑暗的中心:扎伊尔的昏睡病
Lancet. 1996 Nov 23;348(9039):1427-30. doi: 10.1016/S0140-6736(96)06088-6.
9
Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.在刚果民主共和国,用硝呋替莫依氟苯隆组合疗法(NECT)治疗冈比亚锥虫病二期昏睡病患者时的伴随药物处方。
PLoS Negl Trop Dis. 2020 Jan 27;14(1):e0008028. doi: 10.1371/journal.pntd.0008028. eCollection 2020 Jan.
10
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.硝呋替莫-依氟鸟氨酸联合疗法治疗第二阶段冈比亚布氏锥虫病:一项多中心、随机、III期、非劣效性试验
Lancet. 2009 Jul 4;374(9683):56-64. doi: 10.1016/S0140-6736(09)61117-X. Epub 2009 Jun 24.

引用本文的文献

1
Towards elimination: Challenges in community participation to a gHAT 'screen and treat' strategy using the new oral drug acoziborole in the Democratic Republic of the Congo.迈向消除:刚果民主共和国采用新型口服药物阿考齐硼罗实施“筛查与治疗”策略过程中社区参与面临的挑战。
PLoS Negl Trop Dis. 2025 Jun 20;19(6):e0013197. doi: 10.1371/journal.pntd.0013197. eCollection 2025 Jun.
2
The STROGHAT study protocol: An intervention study to evaluate safety, effectiveness and feasibility of treating gambiense HAT seropositive subjects with acoziborole.STROGHAT研究方案:一项评估用acoziborole治疗冈比亚锥虫病血清反应阳性受试者的安全性、有效性和可行性的干预性研究。
Open Res Eur. 2025 Jan 24;5:23. doi: 10.12688/openreseurope.19077.1. eCollection 2025.
3

本文引用的文献

1
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.人类非洲锥虫病图集:对被忽视热带病全球绘图的贡献。
Int J Health Geogr. 2010 Nov 1;9:57. doi: 10.1186/1476-072X-9-57.
2
NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.接下来是NECT:实施针对布氏冈比亚锥虫昏睡病的新联合药物疗法。
PLoS Negl Trop Dis. 2010 May 25;4(5):e720. doi: 10.1371/journal.pntd.0000720.
3
High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
Exploring the value of community engagement activities within a participatory action research study to improve care for people affected by skin neglected tropical diseases in Liberia.在一项参与式行动研究中探索社区参与活动对改善利比里亚皮肤被忽视热带病患者护理的价值。
Res Involv Engagem. 2025 Mar 24;11(1):27. doi: 10.1186/s40900-025-00695-2.
4
The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis.无症状感染的隐性影响阻碍被忽视热带病的控制:一项建模分析
Clin Infect Dis. 2024 Apr 25;78(Suppl 2):S175-S182. doi: 10.1093/cid/ciae096.
5
Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC.不同空间尺度下冈比亚锥虫病随机和确定性模型的比较:刚果民主共和国卫生区分析。
PLoS Comput Biol. 2024 Apr 1;20(4):e1011993. doi: 10.1371/journal.pcbi.1011993. eCollection 2024 Apr.
6
Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo.通过参与刚果民主共和国的采采蝇控制项目增强社区权能。
PLOS Glob Public Health. 2023 Jun 14;3(6):e0001325. doi: 10.1371/journal.pgph.0001325. eCollection 2023.
7
Communities' Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo.刚果民主共和国社区对人类非洲锥虫病的认知、了解及实践
Diseases. 2022 Sep 26;10(4):69. doi: 10.3390/diseases10040069.
8
Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.建模推断动物在刚果民主共和国冈比亚锥虫病传播和消除中的作用。
PLoS Negl Trop Dis. 2022 Jul 11;16(7):e0010599. doi: 10.1371/journal.pntd.0010599. eCollection 2022 Jul.
9
'Where are the dead flies!': perceptions of local communities towards the deployment of Tiny Targets to control tsetse in the Democratic Republic of the Congo.“死苍蝇在哪里!”:当地社区对 Tiny Targets 在刚果民主共和国控制采采蝇部署的看法。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-006879.
10
Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.模拟非昔硝唑的使用对刚果民主共和国人类非洲锥虫病(昏睡病)传播的影响。
PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0009992. doi: 10.1371/journal.pntd.0009992. eCollection 2021 Nov.
在刚果民主共和国,美拉胂醇治疗昏睡病的失败率很高。
Emerg Infect Dis. 2008 Jun;14(6):966-7. doi: 10.3201/eid1406.071266.
4
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.人类非洲锥虫病:与一种被忽视疾病的药理学再接触。
Br J Pharmacol. 2007 Dec;152(8):1155-71. doi: 10.1038/sj.bjp.0707354. Epub 2007 Jul 9.
5
Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.药物毒性和成本成为刚果民主共和国社区参与昏睡病控制的障碍。
Trop Med Int Health. 2007 Feb;12(2):290-8. doi: 10.1111/j.1365-3156.2006.01768.x.
6
Human African trypanosomiasis (sleeping sickness): epidemiological update.人类非洲锥虫病(昏睡病):流行病学最新情况
Wkly Epidemiol Rec. 2006 Feb 24;81(8):71-80.
7
Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.1993 - 2003年刚果民主共和国的锥虫病防治工作
Emerg Infect Dis. 2005 Sep;11(9):1382-8. doi: 10.3201/eid1109.041020.
8
Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.1982年至2001年,刚果民主共和国,美拉胂醇治疗后锥虫病复发情况
Emerg Infect Dis. 2005 Jun;11(6):921-7. doi: 10.3201/eid1106.050036.
9
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.在刚果民主共和国开展积极人群筛查和治疗以控制昏睡病的效果。
Trop Med Int Health. 2004 May;9(5):542-50. doi: 10.1111/j.1365-3156.2004.01240.x.
10
Trypanosoma brucei gambiense African trypanosomiasis: differences between men and women in severity of disease and response to treatment.
Trans R Soc Trop Med Hyg. 2002 Jul-Aug;96(4):421-6. doi: 10.1016/s0035-9203(02)90380-9.